Your browser doesn't support javascript.
loading
Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trial.
Landi, Antonio; Heg, Dik; Frigoli, Enrico; Tonino, Pim A L; Vranckx, Pascal; Pourbaix, Suzanne; Chevalier, Bernard; Iñiguez, Andrés; Pinar, Eduardo; Lesiak, Maciej; Kala, Petr; Donahue, Michael; Windecker, Stephan; Roffi, Marco; Smits, Pieter C; Valgimigli, Marco.
Afiliación
  • Landi A; Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Università della Svizzera Italiana, CH-6900, Lugano, Switzerland; The Faculty of Biomedical Sciences, University of Italian Switzerland (USI), CH-6900 Lugano, Switzerland.
  • Heg D; The Department of Clinical Research (DCR), University of Bern, Bern, Switzerland.
  • Frigoli E; Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Università della Svizzera Italiana, CH-6900, Lugano, Switzerland.
  • Tonino PAL; The Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands.
  • Vranckx P; The Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.
  • Pourbaix S; Department of Cardiology, CHR Citadelle Liège, Liège, Belgium.
  • Chevalier B; the Ramsay Générale de Santé, Interventional Cardiology Department, Institut Cardiovasculaire Paris Sud, Massy, France.
  • Iñiguez A; Hospital Alvaro Cunqueiro, Vigo, Spain.
  • Pinar E; Hospital Virgen de la Arrixaca, Murcia Spain.
  • Lesiak M; The First Department of Cardiology, University of Medical Sciences, Poznan, Poland.
  • Kala P; The University Hospital Brno, Medical Faculty of Masaryk University Brno, Czech Republic.
  • Donahue M; The Interventional Cardiology Unit, Policlinico Casilino, Rome, Italy.
  • Windecker S; The Department of Cardiology, Bern University Hospital, Bern, Switzerland.
  • Roffi M; The Division of Cardiology, Geneva University Hospitals, Geneva Switzerland.
  • Smits PC; The Department of Cardiology, Maasstad Hospital, Rotterdam, the Netherlands.
  • Valgimigli M; Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Università della Svizzera Italiana, CH-6900, Lugano, Switzerland; The Faculty of Biomedical Sciences, University of Italian Switzerland (USI), CH-6900 Lugano, Switzerland; The University of Bern, Bern, Switzerland. Electronic address:
Eur J Intern Med ; 126: 89-94, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38704291
ABSTRACT

AIMS:

Screening logs have the potential to appraise the actual prevalence and distribution of predefined patient subsets, avoiding selection biases, which are inevitably and potentially present in randomised trials and real-world registries, respectively. We aimed to assess the prevalence of high bleeding risk (HBR) characteristics in the real world and the external validity of the MASTER DAPT trial. METHODS AND

RESULTS:

All consecutive patients who underwent percutaneous coronary intervention (PCI) for at least two consecutive weeks across 65 sites participating in the trial were entered into a screening log. Of 2,847 consecutive patients, 1,098 (38.6 %) were HBR and 109 (9.9 %) consented for trial participation. PRECISE-DAPT score ≥ 25 was the most frequent HBR feature, followed by advanced age, use of oral anticoagulation (OAC) and anaemia. Compared with consecutive HBR patients, consenting patients were older (≥ 75 years 69 % versus 62 %, absolute standardized difference [SD] 0.16), more frequently male (78 % versus 71 %, absolute SD 0.18), had higher use of OAC (38 % versus 20 %, absolute SD 0.39), treatment with steroids or nonsteroidal anti-inflammatory drugs (10 % versus 5 %, SD 0.16), and prior cerebrovascular events (10 % versus 6 %, absolute SD 0.18) but lower PRECISE DAPT score ≥ 25 (54 % versus 66 %, absolute SD 0.24).

CONCLUSIONS:

The HBR criteria distribution differed between consecutive versus selectively included HBR patients, suggesting the existence of selection biases in the trial population.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Agregación Plaquetaria / Intervención Coronaria Percutánea / Hemorragia Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2024 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Agregación Plaquetaria / Intervención Coronaria Percutánea / Hemorragia Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2024 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Países Bajos